vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Snowflake Inc. (SNOW). Click either name above to swap in a different company.
Snowflake Inc. is the larger business by last-quarter revenue ($1.2B vs $950.5M, roughly 1.3× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -24.2%, a 24.9% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 28.7%). Snowflake Inc. produced more free cash flow last quarter ($113.6M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 25.1%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Snowflake Inc. is an American cloud-based data platform company founded in San Mateo, California, and headquartered in Bozeman, Montana. It operates a platform that supports data analysis and simultaneous access to data sets with minimal latency. It operates on Amazon Web Services, Microsoft Azure, and Google Cloud Platform.
ASTH vs SNOW — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.2B |
| Net Profit | $6.6M | $-294.0M |
| Gross Margin | — | 67.8% |
| Operating Margin | 1.9% | -27.2% |
| Net Margin | 0.7% | -24.2% |
| Revenue YoY | 42.9% | 28.7% |
| Net Profit YoY | 184.4% | 9.4% |
| EPS (diluted) | $0.12 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.2B | ||
| Q3 25 | $956.0M | $1.1B | ||
| Q2 25 | $654.8M | $1.0B | ||
| Q1 25 | $620.4M | $986.8M | ||
| Q4 24 | $665.2M | $942.1M | ||
| Q3 24 | $478.7M | $868.8M | ||
| Q2 24 | $486.3M | $828.7M | ||
| Q1 24 | $404.4M | $774.7M |
| Q4 25 | $6.6M | $-294.0M | ||
| Q3 25 | $373.0K | $-298.0M | ||
| Q2 25 | $9.4M | $-430.1M | ||
| Q1 25 | $6.7M | $-327.5M | ||
| Q4 24 | $-7.8M | $-324.3M | ||
| Q3 24 | $16.1M | $-316.9M | ||
| Q2 24 | $19.2M | $-317.0M | ||
| Q1 24 | $14.8M | $-169.4M |
| Q4 25 | — | 67.8% | ||
| Q3 25 | — | 67.5% | ||
| Q2 25 | — | 66.5% | ||
| Q1 25 | — | 66.2% | ||
| Q4 24 | — | 65.9% | ||
| Q3 24 | — | 66.8% | ||
| Q2 24 | — | 67.1% | ||
| Q1 24 | — | 68.8% |
| Q4 25 | 1.9% | -27.2% | ||
| Q3 25 | 2.0% | -29.7% | ||
| Q2 25 | 3.1% | -42.9% | ||
| Q1 25 | 3.3% | -39.2% | ||
| Q4 24 | 0.1% | -38.8% | ||
| Q3 24 | 5.9% | -40.9% | ||
| Q2 24 | 6.2% | -42.1% | ||
| Q1 24 | 7.5% | -35.6% |
| Q4 25 | 0.7% | -24.2% | ||
| Q3 25 | 0.0% | -26.0% | ||
| Q2 25 | 1.4% | -41.3% | ||
| Q1 25 | 1.1% | -33.2% | ||
| Q4 24 | -1.2% | -34.4% | ||
| Q3 24 | 3.4% | -36.5% | ||
| Q2 24 | 3.9% | -38.3% | ||
| Q1 24 | 3.7% | -21.9% |
| Q4 25 | $0.12 | $-0.87 | ||
| Q3 25 | $0.01 | $-0.89 | ||
| Q2 25 | $0.19 | $-1.29 | ||
| Q1 25 | $0.14 | $-0.98 | ||
| Q4 24 | $-0.14 | $-0.98 | ||
| Q3 24 | $0.33 | $-0.95 | ||
| Q2 24 | $0.40 | $-0.95 | ||
| Q1 24 | $0.31 | $-0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $2.1B |
| Total Assets | $2.2B | $8.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $1.9B | ||
| Q3 25 | $463.4M | $1.9B | ||
| Q2 25 | $342.1M | $2.2B | ||
| Q1 25 | $260.9M | $2.6B | ||
| Q4 24 | $290.8M | $2.1B | ||
| Q3 24 | $350.3M | $1.3B | ||
| Q2 24 | $327.7M | $1.3B | ||
| Q1 24 | $337.3M | $1.8B |
| Q4 25 | $779.3M | $2.1B | ||
| Q3 25 | $775.5M | $2.4B | ||
| Q2 25 | $765.5M | $2.4B | ||
| Q1 25 | $745.4M | $3.0B | ||
| Q4 24 | $712.7M | $2.9B | ||
| Q3 24 | $704.6M | $4.1B | ||
| Q2 24 | $678.9M | $4.6B | ||
| Q1 24 | $653.5M | $5.2B |
| Q4 25 | $2.2B | $8.2B | ||
| Q3 25 | $2.2B | $8.2B | ||
| Q2 25 | $1.4B | $8.2B | ||
| Q1 25 | $1.3B | $9.0B | ||
| Q4 24 | $1.4B | $8.2B | ||
| Q3 24 | $1.3B | $6.9B | ||
| Q2 24 | $1.3B | $7.3B | ||
| Q1 24 | $1.2B | $8.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $137.5M |
| Free Cash FlowOCF − Capex | $-6.0M | $113.6M |
| FCF MarginFCF / Revenue | -0.6% | 9.4% |
| Capex IntensityCapex / Revenue | 0.3% | 2.0% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $776.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $137.5M | ||
| Q3 25 | $10.0M | $74.9M | ||
| Q2 25 | $90.9M | $228.4M | ||
| Q1 25 | $16.6M | $432.7M | ||
| Q4 24 | $-10.9M | $101.7M | ||
| Q3 24 | $34.0M | $69.9M | ||
| Q2 24 | $23.2M | $355.5M | ||
| Q1 24 | $6.0M | $344.6M |
| Q4 25 | $-6.0M | $113.6M | ||
| Q3 25 | $7.4M | $58.2M | ||
| Q2 25 | $89.5M | $183.4M | ||
| Q1 25 | $13.6M | $421.4M | ||
| Q4 24 | $-13.5M | $88.3M | ||
| Q3 24 | $31.7M | $64.8M | ||
| Q2 24 | $20.4M | $338.9M | ||
| Q1 24 | $5.6M | $331.5M |
| Q4 25 | -0.6% | 9.4% | ||
| Q3 25 | 0.8% | 5.1% | ||
| Q2 25 | 13.7% | 17.6% | ||
| Q1 25 | 2.2% | 42.7% | ||
| Q4 24 | -2.0% | 9.4% | ||
| Q3 24 | 6.6% | 7.5% | ||
| Q2 24 | 4.2% | 40.9% | ||
| Q1 24 | 1.4% | 42.8% |
| Q4 25 | 0.3% | 2.0% | ||
| Q3 25 | 0.3% | 1.5% | ||
| Q2 25 | 0.2% | 4.3% | ||
| Q1 25 | 0.5% | 1.1% | ||
| Q4 24 | 0.4% | 1.4% | ||
| Q3 24 | 0.5% | 0.6% | ||
| Q2 24 | 0.6% | 2.0% | ||
| Q1 24 | 0.1% | 1.7% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SNOW
| Products | $1.2B | 96% |
| Professional Services And Other | $54.5M | 4% |
| Related Party | $6.7M | 1% |
